Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Hematology
•
Sickle Cell
•
Benign Hematology
Would you start a patient with sickle cell disease and COVID-19 on prophylactic anticoagulation?
Related Questions
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?
How do you manage hyperalgesia in patients with sickle cell disease?
In the setting of secondary HLH associated with initial diagnosis of lymphoma, would you adjust steroid dose and type to account for differences in HLH and lymphoma treatment protocols?
Are there any circumstances where you would consider bridging for patients on DOACs?
What additional testing is recommended with heterozygous HFE C282Y mutation whose ferritin is elevated and transferrin saturation percentage is at baseline?
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?
How do you acutely manage bleeding sites of extramedullary hematopoiesis in a patient with transfusion-dependent beta thalassemia?
Would you anticoagulate a patient with splenic infarctions in the setting of CMV viremia?
What is your approach to further work-up and management of neutropenia in patients with SLE/RA overlap?
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
